Topiramate and Metformin Combination for Weight Management in PCOS

Overview

A randomized clinical trial demonstrated that combining topiramate with metformin and a low-calorie diet leads to significantly greater weight loss in women with PCOS compared to metformin alone. The combination also improved androgen levels, lipid profiles, and psychosocial outcomes, with paresthesia being the most common side effect associated with topiramate.

Background

Polycystic ovary syndrome (PCOS) is frequently associated with metabolic dysfunction, including insulin resistance and obesity, which increase cardiometabolic risk. Weight management through lifestyle interventions remains the first-line therapy, but pharmacological agents like metformin are often used to improve metabolic parameters. Topiramate, an antiepileptic drug with appetite-suppressing properties, has recently been investigated for its potential to aid weight loss in PCOS, though its safety and efficacy in this population require further study.

Data Highlights

Key Findings

• Topiramate combined with metformin and a low-calorie diet resulted in a mean weight loss of 4.5% at 6 months versus 1.4% with metformin alone.
• Both treatment groups showed improvements in androgen levels, lipid profiles, and psychosocial scores.
• Paresthesia was the most common side effect in the topiramate group, occurring in 23.3% of participants, typically resolving within 8 weeks.
• Doubling the topiramate dose from 50 mg to 100 mg at 3 months did not enhance weight loss.
• The risk of paresthesia may be influenced by female sex, dosage, and duration of topiramate therapy.
• Topiramate’s use in PCOS is promising but requires further research to clarify long-term safety and efficacy.

Clinical Implications

Clinicians may consider adding topiramate to metformin and dietary interventions for enhanced weight loss in overweight or obese women with PCOS, while monitoring for paresthesia and other side effects. Dose escalation beyond 50 mg daily may not provide additional benefit. Individualized treatment plans should account for PCOS heterogeneity and patient tolerance.

Conclusion

The combination of topiramate and metformin with a low-calorie diet is an effective and generally safe approach to weight management in women with PCOS, though further studies are needed to optimize dosing and evaluate long-term outcomes.

References

1. Marchesan et al 2023 -- Combined Metformin and Topiramate for Weight Management in PCOS
2. Reference 2 -- Side Effects and Dosing of Topiramate
3. Reference 3 -- Metabolic Dysfunction in PCOS
4. Reference 4 -- Lifestyle and Pharmacological Interventions in PCOS
5. Reference 5 -- Topiramate and Phentermine for Obesity
6. Reference 6 -- Topiramate Effects in PCOS
7. Reference 7 -- Adiposity Variations in PCOS Populations